+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1i1r | ||||||
---|---|---|---|---|---|---|---|
タイトル | CRYSTAL STRUCTURE OF A CYTOKINE/RECEPTOR COMPLEX | ||||||
![]() |
| ||||||
![]() | CYTOKINE / cytokine-receptor complex / gp130 / viral IL-6 | ||||||
機能・相同性 | ![]() ciliary neurotrophic factor receptor activity / oncostatin-M-mediated signaling pathway / leukemia inhibitory factor signaling pathway / negative regulation of interleukin-6-mediated signaling pathway / oncostatin-M receptor complex / interleukin-27 receptor activity / ciliary neurotrophic factor receptor binding / ciliary neurotrophic factor-mediated signaling pathway / interleukin-11 receptor activity / interleukin-11 binding ...ciliary neurotrophic factor receptor activity / oncostatin-M-mediated signaling pathway / leukemia inhibitory factor signaling pathway / negative regulation of interleukin-6-mediated signaling pathway / oncostatin-M receptor complex / interleukin-27 receptor activity / ciliary neurotrophic factor receptor binding / ciliary neurotrophic factor-mediated signaling pathway / interleukin-11 receptor activity / interleukin-11 binding / interleukin-27-mediated signaling pathway / ciliary neurotrophic factor receptor complex / interleukin-6 receptor complex / interleukin-6 receptor binding / interleukin-11-mediated signaling pathway / T-helper 17 cell lineage commitment / positive regulation of adaptive immune response / positive regulation of acute inflammatory response / positive regulation of astrocyte differentiation / intestinal epithelial cell development / positive regulation of platelet aggregation / IL-6-type cytokine receptor ligand interactions / Interleukin-27 signaling / Interleukin-35 Signalling / cell surface receptor signaling pathway via STAT / cytokine receptor activity / growth factor binding / Interleukin-6 signaling / glycogen metabolic process / interleukin-6-mediated signaling pathway / positive regulation of cardiac muscle hypertrophy / positive regulation of Notch signaling pathway / MAPK3 (ERK1) activation / cytokine binding / MAPK1 (ERK2) activation / protein tyrosine kinase activator activity / positive regulation of vascular endothelial growth factor production / positive regulation of osteoblast differentiation / coreceptor activity / response to cytokine / positive regulation of T cell proliferation / cytokine activity / cytokine-mediated signaling pathway / scaffold protein binding / negative regulation of neuron apoptotic process / receptor complex / immune response / membrane raft / external side of plasma membrane / neuronal cell body / positive regulation of cell population proliferation / dendrite / negative regulation of apoptotic process / extracellular space / extracellular exosome / extracellular region / identical protein binding / membrane / plasma membrane 類似検索 - 分子機能 | ||||||
生物種 | ![]() ![]() ![]() | ||||||
手法 | ![]() ![]() ![]() | ||||||
![]() | Chow, D. / He, X. / Snow, A.L. / Rose-John, S. / Garcia, K.C. | ||||||
![]() | ![]() タイトル: Structure of an extracellular gp130 cytokine receptor signaling complex. 著者: Chow, D. / He, X. / Snow, A.L. / Rose-John, S. / Garcia, K.C. | ||||||
履歴 |
| ||||||
Remark 300 | BIOMOLECULE: 1 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT WHICH CONSISTS OF 2 CHAIN(S) ...BIOMOLECULE: 1 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). THE BIOLOGICAL ASSEMBLY IS A TETRAMER, OF WHICH HALF (ONE VIL-6, ONE GP130) IS IN THE ASYMMETRIC UNIT. THE DYAD-AXIS OF THE TETRAMER IS THE C2 CRYSTALLOGRAPHIC AXIS. NOTE: COORDINATES FOR THE ENTIRE TETRAMER CAN BE OBTAINED DIRECTLY FROM THE AUTHORS (kcgarcia@stanford.edu). |
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 115.7 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 88.8 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 378 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 393.3 KB | 表示 | |
XML形式データ | ![]() | 12.2 KB | 表示 | |
CIF形式データ | ![]() | 20.2 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| ||||||||
単位格子 |
| ||||||||
詳細 | The second part of the biological assembly is generated by the 2-fold crystallographic axis |
-
要素
#1: タンパク質 | 分子量: 34664.105 Da / 分子数: 1 断片: DOMAINS 1, 2, 3 OF THE GP130 EXTRACELLULAR DOMAIN (RESIDUES 1-303) 由来タイプ: 組換発現 詳細: EXPRESSED IN THE PRESENCE OF INHIBITOR OF N-LINKED GLYCOSYLATION (TUNICAMYCIN) 由来: (組換発現) ![]() 発現宿主: ![]() ![]() 参照: UniProt: P40189 |
---|---|
#2: タンパク質 | 分子量: 20857.197 Da / 分子数: 1 / 由来タイプ: 組換発現 / 詳細: NON-GLYCOSYLATED 由来: (組換発現) ![]() ![]() 属: Rhadinovirus / プラスミド: PACGP67A / 細胞株 (発現宿主): SF9 発現宿主: ![]() ![]() 参照: UniProt: Q98823 |
#3: 水 | ChemComp-HOH / |
Has protein modification | Y |
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 4.07 Å3/Da / 溶媒含有率: 69.77 % | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | 温度: 293 K / 手法: 蒸気拡散法, シッティングドロップ法 / pH: 6.5 詳細: MPEG 2000, sodium citrate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K | ||||||||||||||||||||
結晶 | *PLUS 溶媒含有率: 70 % | ||||||||||||||||||||
結晶化 | *PLUS 手法: unknown | ||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: ![]() ![]() ![]() |
検出器 | タイプ: ADSC QUANTUM 4 / 検出器: CCD / 日付: 2000年9月21日 |
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1 Å / 相対比: 1 |
反射 | 解像度: 2.4→50 Å / Num. all: 34376 / Num. obs: 34376 / % possible obs: 99 % / Observed criterion σ(F): 0 / Observed criterion σ(I): 0 / 冗長度: 3.1 % / Biso Wilson estimate: 50 Å2 / Rmerge(I) obs: 0.081 / Net I/σ(I): 3.4 |
反射 シェル | 解像度: 2.4→2.49 Å / 冗長度: 3.1 % / Rmerge(I) obs: 0.487 / Mean I/σ(I) obs: 1.4 / Num. unique all: 3420 / % possible all: 99.6 |
反射 | *PLUS Num. measured all: 106397 |
反射 シェル | *PLUS % possible obs: 99.6 % |
-
解析
ソフトウェア |
| |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]() 開始モデル: human Interleukin-6 1ALU, gp130 D2D3 domains 1BQU 解像度: 2.4→50 Å / Isotropic thermal model: Isotropic / 交差検証法: THROUGHOUT / σ(F): 0 / σ(I): 0 / 立体化学のターゲット値: Engh & Huber / 詳細: wilson B value 50.2
| |||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 49.1 Å2
| |||||||||||||||||||||||||
Refine analyze |
| |||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.4→50 Å
| |||||||||||||||||||||||||
拘束条件 |
| |||||||||||||||||||||||||
LS精密化 シェル | 解像度: 2.4→2.49 Å / Rfactor Rfree error: 0.019
|